Danaher logo

Danaher dividendNYSE: DHR

Dividend per share (last paid)

$0.27
$0.000.00%

27 September 2024

Dividend per share (next)

-

new highvs 3 years high
+28.57%vs 3 years low
Performance
Most recent0.0%
1 year0.0%
3 years+28.6%
5 years+58.8%

Add series to chart

(max: 6)
company, ETF, index, featured screener or watchlist
series name

Suggested series

Dividend per share (last paid) performance

Most recent change
DHR0.0%
AMGN0.0%
PFE0.0%
SYK0.0%
TMO0.0%
AZN-49.2%
1 year change
DHR0.0%
AMGN+5.6%
PFE+2.4%
SYK+6.7%
TMO+11.4%
AZN+7.5%
3 years change
DHR+28.6%
AMGN+27.8%
PFE+7.7%
SYK+27.0%
TMO+50.0%
AZN+11.1%
5 years change
DHR+58.8%
AMGN+55.2%
PFE+16.7%
SYK+53.9%
TMO+105.3%
AZN+11.1%

Dividend per share (last paid) performance

DHRAMGNISRGPFESYKTMOAZN
Most recent0.0%0.0%-0.0%0.0%0.0%-49.2%
1 year0.0%+5.6%-+2.4%+6.7%+11.4%+7.5%
3 years+28.6%+27.8%-+7.7%+27.0%+50.0%+11.1%
5 years+58.8%+55.2%-+16.7%+53.9%+105.3%+11.1%
FAQ

What is Danaher dividend per share (last paid)?

Danaher dividend per share (last paid) is $0.27

What is Danaher dividend per share (last paid) compared to its all-time maximum value?

Danaher dividend per share (last paid) is 100% of its all-time maximum value

How has Danaher dividend per share (last paid) changed over the year?

Over the past year, Danaher dividend per share (last paid) has not changed. During the same period, Amgen has increased by 5.6%, Pfizer has grown by 2.4%, Stryker has increased by 6.7%, Thermo Fisher Scientific has risen by 11.4%, AstraZeneca has grown by 7.5%

How has Danaher dividend per share (last paid) changed over the 3 years?

During the last 3 years, Danaher dividend per share (last paid) has increased by 28.6%. Over the same period, Amgen has increased by 27.8%, Pfizer has grown by 7.7%, Stryker has increased by 27.0%, Thermo Fisher Scientific has risen by 50.0%, AstraZeneca has grown by 11.1%

How has Danaher dividend per share (last paid) changed over the 5 years?

For the past 5 years, Danaher dividend per share (last paid) has increased by 58.8%. In the same period, Amgen has increased by 55.2%, Pfizer has grown by 16.7%, Stryker has increased by 53.9%, Thermo Fisher Scientific has risen by 105.3%, AstraZeneca has grown by 11.1%